The rise of prescription of psychotropic drugs is a major healthcare problem namely in Psychiatry. The reason of the rise is not clear and many questions remain unanswered. Furthermore, we have more patients, more drugs, more resistant and demanding patients and more polypharmacy. Inappropriate prescribing and lack of rational is not uncommon and prescribing education is also a main concern. Although, the use of guidelines for treatment could make clinical work easier they differ in their objectives and contents. We will discuss the doctor's capacity to make more diagnosis, the problematic of out of label prescriptions and the potential of abuse of some medication and the implications in the rise of prescription. The continuous update and training in clinical psychopharmacology and joint decision-making process between clinicians will allow a rational approach to treatment.
. 2010 Apr 22;9(Suppl 1):S71. doi: 10.1186/1744-859X-9-S1-S71
New patients, new disorders, new drugs and the rise of prescriptions
Luis Camara Pestana
1,✉
Luis Camara Pestana
1Portuguese Association of Biological Psychiatry and Portuguese Authority of Drugs and Pharmacy, Portugal
Find articles by Luis Camara Pestana
1Portuguese Association of Biological Psychiatry and Portuguese Authority of Drugs and Pharmacy, Portugal
✉
Corresponding author.
Supplement
1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance
Konstantinos N Fountoulakis
Conference
19–22 November 2009
1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance
Thessaloniki, Greece
Collection date 2010.
Copyright ©2009 Pestana; licensee BioMed Central Ltd.
PMCID: PMC2991986
